Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objectives: To evaluate associations between high‐density lipoprotein cholesterol (HDL) and non‐HDL‐C levels at specific ages and subsequent Alzheimer's disease (AD) risk. Design: Prospective population‐based cohort study. Setting: Adult Changes in Thought (ACT) Study. Participants: Individuals aged 65 and older with no dementia at ACT Study entry. We identified separate, partially overlapping subcohorts of ACT participants who were eligible for each age band–specific analysis (50–59, n = 1,088; 60–69, n = 2,852; 70–79, n = 2,344; 80–89, n = 537). Measurements: Exposure consisted of clinical measures of total cholesterol (TC) and HDL‐C from laboratory data during a given age band. Outcomes of incident AD were assessed post‐age band using standard research diagnostic criteria. Statistical analyses used adjusted Cox proportional hazards regression models for each exposure and outcome pair within an age band. Cholesterol exposures were modeled using cubic splines. Results: For non‐HDL‐C, we found a statistically significant association with AD risk in the 60 to 69 (omnibus p = .005) and 70 to 79 (omnibus p = .04) age bands, suggesting a potential U‐shaped relationship (greater risk at low and high levels). For example, in people aged 60 to 69, those with an average non‐HDL‐C level of 120 mg/DL had a 29% greater AD hazard (hazard ratio (HR)=1.29, 95% confidence interval (CI)=1.04–1.61) than those with an average non‐HDL‐C level of 160 mg/dL, whereas those with an average non‐HDL‐C level of 210 mg/dL had a 16% greater hazard (HR=1.16, 95% CI=1.01–1.33). We did not find a statistically significant association between HDL‐C and AD risk. Conclusion: People with low (120 mg/dL) and high (210 mg/dL) non‐HDL‐C levels during their 60s and 70s had modestly higher risk of AD than those with intermediate (160 mg/dL) levels. The extreme age bands (50s and 80s) had small sample sizes. J Am Geriatr Soc 66:2344–2352, 2018 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Larson, E. B., Wang, L., Bowen, J. D., McCormick, W. C., Teri, L., Crane, P., & Kukull, W. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-2-200601170-00004 · Cited by 1,463 · cited 2×
“The Adult Changes in Thought (ACT) Study enrolled dementia-free consenting participants randomly sampled from Seattle-area KPW members aged 65 and older starting in 1994 to 1996.(5) Additional details of the ACT study have been previously reported.”
MethodSelf-citationCumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study
Gray, S. L., Anderson, M. L., Dublin, S., Hanlon, J. T., Hubbard, R., Walker, R., Yu, O., Crane, P. K., & Larson, E. B. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7663 · Cited by 1,111 · cited 1×
“Timing of AD or dementia onset was set as the midpoint between the ACT visit that triggered the diagnosis and the preceding visit, as is ACT’s convention.(13,14) For the analyses of AD, onset of non-AD dementia was treated as a censoring event.”
MethodSelf-citationDementia and Alzheimer Disease Incidence: A Prospective Cohort Study
Kukull, W. A., Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., van Belle, G., Jolley, L., & Larson, E. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1737 · Cited by 806 · cited 1×
“Results of these evaluations and laboratory and imaging records were then reviewed in a multidisciplinary consensus conference.(8) Diagnoses of dementia and probable or possible AD were made using research criteria.”
MethodSelf-citationAnstey, K. J., Ashby-Mitchell, K., & Peters, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160826 · Cited by 360 · cited 4×
“Moreover, studies evaluating midlife cholesterol lacked clear information on age of cholesterol exposure.(4) To address some of these gaps, we evaluated extensive longitudinal clinical data from a prospective cohort with From the *Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washingto…”
BackgroundMethodInfluentialGray, S. L., Dublin, S., Yu, O., Walker, R., Anderson, M., Hubbard, R. A., Crane, P. K., & Larson, E. B. (2016) · BMJ · doi:10.1136/bmj.i90 · Cited by 233 · cited 1×
“Timing of AD or dementia onset was set as the midpoint between the ACT visit that triggered the diagnosis and the preceding visit, as is ACT’s convention.(13,14) For the analyses of AD, onset of non-AD dementia was treated as a censoring event.”
MethodSelf-citationStatins, cognition, and dementia-systematic review and methodological commentary
Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.35 · Cited by 150
Tsuang, D., Kukull, W., Sheppard, L., Barnhart, R. L., Peskind, E., Edland, S. D., Schellenberg, G., Raskind, M., & Larson, E. B. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01836.x · Cited by 69
Self-citation
Cited by
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention
Zhang, X.-X., Tian, Y., Wang, Z.-T., Ma, Y.-H., Tan, L., & Yu, J.-T. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.15 · Cited by 789
“…and non-HDL-C in the Adult Changes in Thought (ACT) Study, the finding revealed a U-shaped association of non-HDL-C level with risk of AD among 60-69 aged individuals, compared with 160 mg/dl non-HDL-C, the HR was 1.29 (95% CI 1.04-1.61) at 120 mg/dl and 1.16 (95% CI 1.01-1.33) at 210 mg/dl (42).”
InfluentialHDL from an Alzheimer's disease perspective
Button, E. B., Robert, J., Caffrey, T. M., Fan, J., Zhao, W., & Wellington, C. L. (2019) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000604 · Cited by 114
Midlife lipid and glucose levels are associated with Alzheimer's disease
Zhang, X., Tong, T., Chang, A., Ang, T. F. A., Tao, Q., Auerbach, S., Devine, S., Qiu, W. Q., Mez, J., Massaro, J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12641 · Cited by 65
Peters, R., Xu, Y., Antikainen, R., Beckett, N., Gussekloo, J., Jagger, C., Jukema, J. W., Keinanen-Kiukaanniemi, S., Rydén, L., Skoog, I., et al. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000519452 · Cited by 51
Metadata
- Authors
- Marcum, Z. A., Walker, R., Bobb, J. F., Sin, M., Gray, S. L., Bowen, J. D., McCormick, W., McCurry, S. M., Crane, P. K., & Larson, E. B.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2018-10-05
- Volume
- 66
- Issue
- 12
- Pages
- 2344-2352
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2895195076
- Cited by
- 34
- References
- 8
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study. https://app.cochat.ai/papers/10.1111/jgs.15581
- The paper
- Marcum, Z. A., Walker, R., Bobb, J. F., Sin, M., Gray, S. L., Bowen, J. D., McCormick, W., McCurry, S. M., Crane, P. K., & Larson, E. B. (2018). Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.15581
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.